PTK6 and breast cancer: Therefore, the four human breast cancer cell lines (MBA-MD-231, MCF-7, BT-474 and T-47D) were chosen to identify the mechanism of action by which SPA inhibits breast cancer cell proliferation and motility and the potential involvement of Brk and FAK signaling.